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Prior CABG
(n250)
No Prior
CABG
(n3292) P-Value
Culprit SVG
(n81)
Native
Culprit
(n99)
No Culprit
(n57) P-Value
Age (Yrs),
mean(SD)
69.4 	/
12.0
62.0 	/
14.3
0.001 68.5 	/
11.4
68.7
	/
11.6
69.2 	/
12.4
0.90/
0.95
Male, (%) 204 (81.6) 2324
(70.6)
0.001 67 (82.7) 83
(83.8)
45 (79.0) 0.84/
0.74
BMI, mean(SD) 28.6 	/
5.7
28.9 	/
6.0
0.40 28.6 	/
4.7
28.5
	/
6.0
28.8 	/
6.7
0.90/
0.97
OOHCA, (%) 15 (6.0) 296 (9.0) 0.11 3 (3.7) 6 (6.1) 4 (7.0) 0.47/
0.67
Shock Pre-PCI,
(%)
20 (8.0) 279 (8.5) 0.79 11 (13.6) 4 (4.0) 4 (7.0) 0.021/
0.061
History of
smoking, (%)
147 (59.5) 1995
(61.0)
0.64 52 (64.2) 47
(48.0)
42 (73.7) 0.03/
0.004
Current Smoker-,
(%)
47 (32.0) 1233
(61.8)
0.001 17 (32.7) 18
(38.3)
10 (23.8) 0.56/
0.34
Diabetes, (%) 89 (35.7) 518 (15.8) 0.001 29 (35.8) 30
(30.6)
23 (40.4) 0.46/
0.46
EF (%), mean(SD) 45.3 	/
14.4
47.4 	/
13.3
0.020 45.0 	/
13.8
45.4
	/
14.6
48.2 	/
14.3
0.82/
0.42
Killip Class 0.98 0.061/
0.15
0/1, (%) 218 (87.2) 2867
(87.1)
67 (82.7) 91
(91.9)
48 (84.2)
2/4, (%) 32 (12.8) 423 (12.9) 14 (17.3) 8 (8.1) 9 (15.8)
Intervention
Done, (%)
169 (67.6) 2622
(79.8)
0.001 71 (87.7) 94
(95.0)
2 (3.5) 0.078/
0.001
D2B (mins),
median (25th,
75th percentile)
98 (74,
124)
95 (74,
124)
0.35 95 (75,
119)
98
(75,
119)
107 (84,
130.5)
0.87**/
0.27**
Death In Hospital,
(%)
12 (4.8) 165 (5.0) 0.88 6 (7.4) 2 (2.0) 2 (3.5) 0.081/
0.19
Death at 30
Days, (%)
12 (4.8) 189 (5.7) 0.54 6 (7.4) 2 (2.0) 2 (3.5) 0.081/
0.19
Death at 1 Year,
(%)
27 (10.8) 295 (9.0) 0.33 10 (12.4) 7 (7.1) 4 (7.0) 0.23/0.40
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Background: Several clinical and angiographic scores have been proposed for the
prediction of the outcome of patients with myocardial infarction undergoing primary
percutaneous coronary angiography (PCI). The aim of this study was to assess the ability
of Clinical Syntax Score (CSS) for predicting outcome late after successful primary PCI.
Methods: 345 consecutive patients that underwent successful primary PCI due to STEMI
in our hospital were recruited out of 361 primary PCIs. CSS was calculated for each
patient as previously described. The patients were followed by outpatient visit or
telephone for 2 years. Endpoints included all-cause death, cardiac death, repeat revascu-
larization (RR), stent thrombosis (ST) and major adverse cardiac event (MACE), defined
as the composite of death, myocardial infarction, or target vessel revascularization.
Results: The median follow-up period was 476 days (mean 4965 days). Table 1
presents the 2-year outcomes according to CSS tertile, while the figure shows Kaplan-
Meier curves for freedom from cardiac death and MACE, respectively, stratified by CSS
tertile. CSS score was higher in patients with death or cardiovascular death, RR and
MACE.
CSS LOW
(n117)
CSS MID
(n109)
CSS HIGH
(n119) p-value
Total Death 6 (5.1%) 14 (12.8%) 22 (18.4%) 0.007
Cardiac death 1(0.8%) 5 (4.5%) 13 (10.9%) 0.02
ST 0 (0%) 0 (0%) 2(1.6%) 0.14
RR 5 (4.2%) 4(3.6%) 15 (12.6%) 0.01
MACE 5 (4.2%) 6 (5.5%) 20(16.8%) 0.001
Conclusions: CSS is a reliable tool for assessing outcome after successful PCI in patients
with myocardial infarction and successful primary PCI.
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elevation myocardial infarction
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Eak Kyun Shin2, Soon Yong Suh2
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Background: There were no published data regarding the clinical efficacy and safety of
second generation drug-eluting stent (zotarolimus-eluting stent with biolinx polymer,
ZES-BP, Endeavor resolute) following primary percutaneous coronary intervention (PCI)
in ST-elevation myocardial infarction (STEMI). We evaluated the one-year outcome of
zotarolimus-eluting stent with biolinx polymer versus to 1st generation (sirolimus-eluting
stent, SES and paclitaxel-eluting stent, PES) and 2nd generation (zotarolimus-eluting
stent, ZES and everolimus-eluting stent, EES) drug-eluting stents(DES) for the treatment
of STEMI.
Methods: A prospective, open-labeled, multi-center cohort has been performed. The
primary endpoint was major adverse cardiac event (MACE): the composite of cardiac
death (CD), recurrent MI and ischemia-driven target vessel revascularization (TVR) at 1
year. Stent thromboses (ST) by ARC definition were analyzed.
Results: Total 975 patients (ZES-BP178, EES197, ZES203, SES203,
PES194) were analyzed. One-year MACE were 3.4%, 2.0%, 5.9%, 3.4% and 5.7% in
ZES-BP, EES, ZES, SES and PES group, respectively (pns). Cardiac death were 2.3%,
1.0%, 2.5%, 1.5% and 1.0% in ZES-BP, EES, ZES, SES and PES group, respectively
(pns).
Conclusions: Compared to 1st and 2nd generation DES (SES and PES, ZES), EES and
ZES-BP showed similar one-year clinical outcomes in terms of MACE in patients with
STEMI following primary PCI and no stent thrombosis.
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Predictors and Clinical Outcomes Related to Door-in Door-out Times
Ross Garberich1, Stephanie Rutten-Ramos1, Anil Poulose1, David Larson1,
Timothy Henry1
1Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital,
Minneapolis, MN
Background: Recent studies suggest door in-door out (DIDO) time may predict
outcomes in ST-elevation myocardial infarction (STEMI) patients transferred from a
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non-percutaneous coronary intervention (PCI) facility. ACC/AHA Clinical AMI Perfor-
mance Measures recommend a benchmark of 30 minutes DIDO time. However, recent
studies indicate this is difficult to achieve. Our goal was to evaluate the effect of various
DIDO times on clinical outcomes.
Methods: Using a comprehensive prospective regional STEMI program database, we
evaluated the outcome of STEMI patients based on DIDO times of 30 minutes, 30-45
minutes, 46-60 minutes, 61-90 minutes, and 90 minutes.
Results: Of 3,435 consecutive STEMI patients who presented to the Minneapolis Heart
Institute at Abbott Northwestern Hospital regional STEMI system 4/03 to 12/11, 2,589
were transferred from non-PCI facilities (Zone 1 0-60 miles, Zone 2 60-210 miles). The
baseline characteristics and outcomes for the DIDO groups are shown in Table 1. Longer
DIDO times occurred in patients with increased age, history of diabetes, presentation
during off-peak hours, self-transfer to non-PCI hospital, no intervention performed, and
Zone 2 patients. As expected, patients with shorter DIDO times were more likely to have
a door to balloon time 120 minutes, but there was basically no difference in 30 and
30-45 minutes groups (96.5% vs. 94.5%). Patients with DIDO 90 were less likely to
have a culprit artery which required an intervention. When adjusted for difference in
baseline characteristics, there were no differences in 30 day or 1 year mortality.
Conclusions: DIDO time is a complex measure influenced by many factors. There is
with basically no difference in clinical outcomes for patients with DIDO 30 compared
to 30-45 minutes. Clinical outcomes appear to be more related to factors which increase
DIDO time than the time itself.
DIDO 0-30
(n279)
DIDO 31-45
(n649)
DIDO 46-60
(n651)
DIDO 60-90
(n613)
DIDO>90
(n374) P-value
Age (Yrs), (Mean (SD)) 60.5 (13.1) 61.4 (13.8) 62.0 (14.0) 64.1 (14.7) 63.7 (14.9) 0.001
Male (N/%) 208/74.6% 482/74.3% 469/72.0% 428/69.8% 259/69.3% 0.25
Diabetes Mellitus (N/
%)
42/15.1% 86/13.3% 101/15.6% 115/18.8% 74/19.8% 0.027
Initial Hospital Zone 1
(N/%)
213/76.3% 476/73.7% 372/57.1% 291/47.6% 177/47.5% 0.001
Presentation to ANW
during traditional
peak hours (N/%)
120/43.2% 234/36.1% 229/35.2% 196/32.0% 115/30.8% 0.008
Mode of Arrival IH—
Ambulance (N/%)
189/67.7% 251/38.7% 229/35.2% 217/35.4% 105/28.1% 0.001
Prior ED Activation
(N/%)
45/16.1% 65/10.0% 49/7.53% 27/4.4% 26/7.0% 0.001
Cardiac Arrest—Pre
PCI & In Cath (N/%)
28/10.04% 69/10.63% 72/11.06% 84/13.7% 38/10.16% 0.50
Cardiogenic shock
(N/%)
20/7.3% 40/6.4% 56/8.8% 61/10.2% 35/9.5% 0.13
Intervention
performed (N/%)
242/86.74% 543/83.67% 519/79.72% 467/76.18%250/66.84% 0.001
Door to Balloon 
120 minutes (%) (95%
Wald CL)
96.5%
(21.5,
100)a
94.5%
(21.3, 100)a
84.1%
(18.9, 100)a
46.0%
(10.2, 100)b
3.6% (1.7,
7.5)c
0.001†
30 day mortality, (%)
(95% Wald CL)*
4.8% (0.6,
36.0)
6.5% (1.1,
37.8)
5.7% (1.0,
33.1)
5.3% (0.9,
30.2)
11.5%
(3.4,
38.2)
0.18
1 year mortality (%)
(95% Wald CL)**
5.5%
(0.9%,
32.0%)
8.0% (1.7%,
38.3%)
6.8% (1.4%,
32.8%)
8.4% (1.8%,
39.2%)
10.2%
(3.3%,
31.5%)
0.27
abcEstimates with the same superscripts do not differ (p0.05)
*Mortality rates adjusted for baseline differences of age, intervention performed, cardiac arrest, and
cardiogenic shock
**Mortality rates adjusted for age, intervention performed, arrival mode to tertiary hospital, cardiac
arrest, and cardiogenic shock, and cardiac arrest “Cool-It” patient
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Søren Becker1, Gro Chisholm2, Michael Maeng3
1Aarhus University Hospital, Skejby, Aarhus, Denmark, 2Skejby University
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Background: Fibrinolysis has not been used for the treatment of ST-segment elevation
myocardial infarction (STEMI) in Denmark since 2005. The aim of the present study was
to assess the positive predictive value of clinically suspected STEMI among consecutive
patients in a real-world setting where all patients with suspected STEMI undergo acute
coronary angiography.
Methods: We evaluated the clinical diagnosis of consecutive patients with suspected
STEMI admitted to Aarhus University Hospital between September 1, 2010 and August
31, 2011 who underwent acute angiography. Conclusive STEMI was defined as a patient
with an, by angiography, identifiable culprit lesion.
Results: Of 615 patients with suspected STEMI, 483 (79%) had conclusive STEMI while
132 (21%) did not have an identifiable culprit lesion. Patients with conclusive STEMI had
a higher proportion of male gender (73% versus 60%; P0.004), advanced age (mean, 64
versus 62 years; P0.005), and a lower ejection fraction (47% versus 50%; P0.003).
Patients without conclusive STEMI were more likely to have diabetes (16% versus 10%;
P0.04), left bundle branch block (24% versus 2%; P0.001), hypertension (48% versus
36%; P0.01), or a history of coronary artery bypass surgery (8% versus 2%; P0.001).
Among patients without conclusive STEMI, 41% had positive biomarkers and a number
of differential diagnoses were identified.
Conclusions: In this real-world setting, the positive predictive value of clinically
suspected STEMI was 79%. A substantial number of “false-positive” patients would have
received fibrinolysis if acute angiography had not been available.
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Nobuyuki Kuroiwa1, Shigeru Fukuzawa1, Soichiro Ichikawa1, Atsushi Ikeda1,
Masayuki Inagaki1, Junpei Maekawa1, Shuichi Okamoto1, Shinichi Okino1,
Juji Sugioka1
1Funabashi Municipal Medical Center, Chiba, Japan, Funabashi CIty, Chiba
Background: Tragic magnitude 9.0 earthquake hit Northeast Japan on 11 March 2011.
Even at Medical center in Chiba prefecture which is located 400 km away from a
hypocenter have experienced a strong quake. City‘s function was thrown into confusion
for couple of days, but not so many people were reported to be dead in our medical district
and population change was limited. According to the past statistics, in such a disastrous
situation, tend to increase acute myocardial infarction (AMI) patients. Our objective was
to investigate whether disaster stress will increase AMI patients.
Methods: Retrospective study was performed at Funabashi Municipal Medical Center,
Division of Cardiology, Heart and Vessel Institute, Chiba, Japan. We have compared 307
patients who were hospitalized for AMI between Mar11th to Aug 10th (6 month period)
for years 2006 to 2012. For year 2012, only March to June data was included. Monthly
figure stands for 11th of the month to 10th of next month. The age was from 32 to 92
(mean 67.611.7) and gender were Male 250 and Female 57. Study was made between
2006 to 2010 plus 2012 group and 2011 group.
Results: The number of AMI patient for 2011 March was 15 (14 underwent percutaneous
coronary intervention) and average for 2006 to 2010 plus 2012 group was only at 5.7. The
AMI number after catastrophe increased by 163% and strong correlation between the
number of aftershock and AMI were seen. There were no significant difference between
groups in age, gender, coronary risk factors, culprit lesion and mean blood pressure at
arrival.
Number of
AMI
patients Mar Apr May Jun Jul Aug
2006 5 7 4 8 4 2
2007 5 13 4 7 15 8
2008 4 12 6 4 8 8
2009 9 4 9 15 10 9
2010 6 12 8 7 8 11
2012 5 11 9 - - -
2006-2010
& 2012
average
5.7 9.8 6.7 8.2 9 7.6
2011
(change%)
15
(163%)
4
(59%)
10
(49%)
7
(15%)
6
(33%)
8
(5%)
Conclusions: This study demonstrates that disaster stress might be the risk factor for
AMI and increases hospitalized patients. Also we have experienced the importance of PCI
facility running after the catastrophe since number of patients will increase. Over all,
further investigation using large number of cases is necessary. Multiple center investiga-
tion is required.
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Impact of High High-Density Lipoprotein-Cholesterol on 1-year Outcome of
Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary
Intervention
Yun-Kyeong Cho1, Ji-Hyun Sohn1, Hyun-Ok Cho1, Hyoung-Seob Park1,
Hyuck-Jun Yoon1, Hyungseop Kim1, Chang-Wook Nam1, Seung-Ho Hur1,
Yoon-Nyun Kim1, Kwon-Bae Kim1
1Keimyung University Dongsan Hospital, Daegu, Korea, Republic of
Background: High-density lipoprotein-cholesterol (HDL-C) is a continuous inverse
cardiovascular risk factor. However, little is known about the influence of HDL-C on
outcome of patients with acute coronary syndrome (ACS) undergoing percutaneous
coronary intervention (PCI).
Methods: A total of 2169 consecutive patients with ACS underwent elective PCI was
enrolled. We evaluated the impact of HDL-C on 1-year occurrence of death, non-fatal
myocardial infarction and target lesion revascularization. The patients were divided into
2 groups: high HDL-C ( 50 mg/dL for female and  40 mg/dl for male) and low
HDL-C ( 50 mg/dL for female and  40 mg/dl for male).
Results: patients with high HDL-C had a higher incidence of male and hypercholester-
olemia. After correction for baseline differences, patients with high HDL-C had a
significant lower 1-year outcome (OR 0.567, 95% CI 0.402-0.799, p0.001).
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